Top Stories Pfizer yanks sickle-cell treatment worldwide after possible link to deaths September 25, 2024 The benefits of Oxbryta no longer outweigh the risks, Pfizer says.
Get ready for Netflix price increases soon, analysts say Netflix hasn’t raised prices on its standard plan in years, and analysts think the company’s strong upcoming content slate could... October 10, 2024
Homeowners haven’t drained cash out of their houses this fast since 2008 Homeowners across the U.S. may be locked in, but they can still cash out. October 10, 2024
Buy Nike’s stock now, as new management can excite investors again, analyst says It’s time to start buying Nike Inc.’s stock, as a new management team of company veterans should reignite investor excitement... October 10, 2024
Amazon’s Prime Big Deal Days was its biggest-ever October shopping event Amazon.com Inc. said Thursday its Prime Big Deal Days was its biggest October shopping event ever, as Prime members took... October 10, 2024
Where Nvidia ranks among fastest-growing AI companies. No, it’s not No. 1. Others ranking high on a broad list of AI stocks include AMD and Micron. October 10, 2024
Tilray’s stock gains after earnings and upbeat outlook on cannabis legalization Tilray’s stock gained Thursday, after the cannabis and beverage company reported a smaller loss than expected for its fiscal first... October 10, 2024
